MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
The Regional Account Manager (RAM) is a field-based commercial professional responsible for developing and growing Mirum’s cholestatic disease portfolio within an assigned territory in Italy.
Working in close partnership with healthcare professionals and multidisciplinary care teams, the RAM develops and executes territory account plans that improve patient access and support appropriate use of Mirum’s therapies. The RAM combines strong clinical knowledge with commercial excellence to build trusted customer relationships, identify opportunities, and deliver sustainable business growth.
Working collaboratively with Medical Affairs, Market Access, Compliance and other cross-functional partners, the RAM translates customer insights into effective account strategies while ensuring all activities comply with applicable legal, regulatory and company requirements.
JOB FUNCTIONS/RESPONSIBILITIES
- Develop and execute territory account plans aligned with national commercial objectives.
- Build and maintain productive relationships with healthcare professionals, key opinion leaders and multidisciplinary care teams.
- Deliver high-quality scientific and product discussions that support appropriate patient care.
- Identify customer needs and align Mirum resources and solutions to improve patient outcomes.
- Continuously assess territory opportunities using customer insights, market intelligence and business data.
- Collaborate effectively with cross-functional colleagues to deliver coordinated customer engagement.
- Maintain exceptional knowledge of disease states, treatment landscape and Mirum’s products.
- Demonstrate accountability for territory performance while consistently operating in compliance with company policies and applicable regulations.
- Contribute positively to a collaborative 'One Mirum' culture by sharing best practices and supporting team success.
QUALIFICATIONS
Education/Experience:
- 10+ years of business experience in healthcare or biotech industry in RAM roles
- Significant experience in Regional Market access
- Successful biotech/pharma product launch experience in rare or niche markets with a documented track record of exceeding goals in competitive markets. Experience in Liver diseases will be an important plus
- Bachelor’s in science degree or higher
- Existing relationships within GI, hepatology or related specialty areas preferred.
- Experience working with hospitals, academic centres and multidisciplinary care teams preferred.
- Experience in liver and / or rare diseases is an important tplus.
- Strong understanding of customer engagement and account planning.
- Demonstrated ability to work collaboratively across functions.
- Commitment to compliance and ethical business practices.
- Willingness to travel approximately 80%, including overnight travel.
- Fluency in Italian and English (written and spoken).
Knowledge, Skills and Abilities
- Patient centricity and commitment to improving outcomes for rare disease patients.
- Strong territory planning and execution skills.
- Effective influencing and stakeholder management skills.
- Accountability, resilience and growth mindset.
- Strong clinical acumen and commitment to continuous learning.
- Excellent collaboration and cross-functional teamwork.
****Please submit your CV in English language***
The base salary range for this position is EUR 87,000 to EUR 97,000. Starting compensation within this range will be determined based on objective, job-related factors, including relevant skills, qualifications, experience, and geographic work location. Compensation is provided in accordance with the National Collective Bargaining Agreement for employees of companies in the Pharmaceutical chemicals sector (the "NCBA"), as applicable. The salary range reflects base salary only and does not include bonus, equity, or benefits unless otherwise stated.
#LI-REMOTE
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Skills Required
- 10+ years of business experience in healthcare or biotech industry in RAM roles
- Significant experience in Regional Market access
- Successful biotech/pharma product launch experience in rare or niche markets with documented track record of exceeding goals
- Bachelor's degree in science or higher
- Strong understanding of customer engagement and account planning
- Demonstrated ability to work collaboratively across functions
- Commitment to compliance and ethical business practices
- Willingness to travel approximately 80%, including overnight travel
- Fluency in Italian and English (written and spoken)
- Existing relationships within GI, hepatology or related specialty areas
- Experience working with hospitals, academic centres and multidisciplinary care teams
- Experience in liver and/or rare diseases
Mirum Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Mirum Pharmaceuticals and has not been reviewed or approved by Mirum Pharmaceuticals.
-
Equity Value & Accessibility — Equity grants to new hires and an employee stock purchase plan make ownership more accessible and can boost total rewards when performance is strong. Public disclosures highlight frequent option/RSU inducements.
-
Healthcare Strength — Comprehensive medical, dental, and vision coverage is employer-paid for employees, with added life, disability, and EAP support. This combination reduces financial burden and enhances overall wellbeing.
-
Leave & Time Off Breadth — A broad time-off program includes multiple paid company holidays, a year-end shutdown, accrued vacation, and paid parental leave. This breadth provides additional rest periods beyond standard vacation.
Mirum Pharmaceuticals Insights
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome. Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome. Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
